AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
about
Cognitive enhancers for the treatment of ADHDNicotine addictionNootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulatorsDifferential immediate and sustained memory enhancing effects of alpha7 nicotinic receptor agonists and allosteric modulators in ratsnAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disordersMuscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophreniaBeyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia.alpha7 Nicotinic acetylcholine receptors and temporal memory: synergistic effects of combining prenatal choline and nicotine on reinforcement-induced resetting of an interval clock.Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.Activation of presynaptic alpha7 nicotinic receptors evokes an excitatory response in hippocampal CA3 neurones in anaesthetized rats: an in vivo iontophoretic studySpecific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques.Pharmacology of nicotine: addiction, smoking-induced disease, and therapeuticsDecreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats.α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.An experimental study on (131)I-CHIBA-1001: a radioligand for α7 nicotinic acetylcholine receptors.AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation.Pharmacology of nicotinic receptors in preBötzinger complex that mediate modulation of respiratory pattern.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.An autoradiographic analysis of rat brain nicotinic receptor plasticity following dietary choline modification.Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task.Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury.Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice.Complex relationships of nicotinic receptor actions and cognitive functions.Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder.Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptorsVoltage- and Temperature-Dependent Allosteric Modulation of α7 Nicotinic Receptors by PNU120596.Biological basis of tobacco addiction: Implications for smoking-cessation treatment.The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS-21): Chemical and Pharmacological Properties.The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials.Excitation of rat hippocampal interneurons via modulation of endogenous agonist activity at the alpha7 nicotinic ACh receptor.
P2860
Q22251235-F059A3DD-3B49-4AA8-957B-7B51FBF66523Q24626554-3D5E9C82-E59D-4AD2-BE7C-D181DE9FAF4DQ24681828-A2EC64AF-A982-430B-934E-DC21C85134D5Q28477881-8C14BE70-CD43-45B0-868A-E4BEA9297C63Q30362464-139F7D4A-50EB-4DAC-BB69-91BEF94D6E61Q30372351-B17576F0-2F4F-489D-8BD0-B66DD15F2ED4Q30459624-6A8E9601-377A-4B0A-A5D6-370C417D2EE8Q30473410-BDDC2086-34AA-4ED0-9DB8-01D3C8A23168Q30478035-8E55B029-52EF-4902-B768-2EA07BF78FAEQ30500484-B2CB8F7E-A947-4022-9323-F76C6E7B6F91Q33598688-3176121D-30FA-44A5-AE17-EC3081FA70BEQ33685905-3298FEFF-DEFB-4ECC-A9FC-46F578B753AAQ33952134-3E8D2029-AB2C-464B-8127-F28B3A97D224Q34157674-330EDB6D-E1F7-4354-B89D-0FCD45B86B19Q34287941-9A0F0543-287A-4455-A324-A5033180B87BQ34501147-52AF90AE-BE41-4281-841D-FDAE669A261EQ34922142-E8BA1493-AA8B-4BF9-B78F-50D6B1D63923Q35111465-1AF5FE37-C01E-423F-93A9-DBFDC8603626Q35111894-D69B5EEF-BFE4-4000-8D13-4843DD3C3BA8Q35264378-95BAFE82-A2D5-482C-A6E8-2EDB5C8A622CQ35990855-C8EF6945-5F41-4C2A-901E-E28E2D0E71D1Q36015229-1A0D488A-66A6-4CB6-A1BF-FE86EEF85D28Q36830205-03C31A55-8BB4-472F-A42A-10AB4828BE6DQ36917265-EF7ECCAF-33CD-4CC7-B7C8-BA1F2D5F6DC2Q37089670-44B81165-3D2C-49C2-B188-E2893AABE910Q37230988-B03E2BE3-43E9-4B06-AB56-88A63F0CEABFQ37376724-F03C39AF-94F0-44F5-BB56-F2C2028C1FF2Q37395740-C8DC5FC6-53C6-4945-B4E0-D2BBD1696153Q37728112-6AB89F0B-FB27-41EB-8788-E4944DDF2C8DQ38269008-66A160CD-912A-409F-B856-41B9B7547046Q39306177-CE09DB0B-351A-4096-8980-EF8FC333BD81Q39997704-AD161AEF-F988-4BAC-8655-C5CDE776B6D3Q42022968-FE01B8D5-28E5-4B38-8049-7D6E0B91A939Q46776125-F35C5B0B-D815-48C4-A508-153B63FDC397Q47127039-82F9D17E-FC61-4A07-BF1D-2A6ADE8E3A01Q48544070-97A8531A-2FF5-4E36-B41C-9F056251656E
P2860
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
@ast
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
@en
type
label
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
@ast
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
@en
prefLabel
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
@ast
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
@en
P2093
P1476
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats
@en
P2093
P304
P356
10.1097/00008877-199911000-00014
P577
1999-11-01T00:00:00Z